Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine-Reference-Cited by-同舟云学术

Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine

Published:2015-06-03 Issue:6 Volume:11 Page:1306-1312
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Luxembourg Alain,Moreira Edson D,Samakoses Rudiwilai,Kim Kyung-Hyo,Sun Xiao,Maansson Roger,Moeller Erin,Christiano Susan,Chen Joshua

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/21645515.2015.1009819

Reference12 articles.

1. Lot Consistency as an Equivalence Problem

2. Food and Drug Administration Regulation and Evaluation of Vaccines

3. Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults;Vaccine;2023-11

2. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety;Pediatrics;2023-09-05

3. Chemoprevention of Cancer;Holland‐Frei Cancer Medicine;2022-10-21

4. Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants;Human Vaccines & Immunotherapeutics;2022-08-23

5. Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review;Vaccines;2022-02-08